PRIMARY IMMUNODEFICIENCY DISEASES (PID)
Clinical trials for PRIMARY IMMUNODEFICIENCY DISEASES (PID) explained in plain language.
Never miss a new study
Get alerted when new PRIMARY IMMUNODEFICIENCY DISEASES (PID) trials appear
Sign up with your email to follow new studies for PRIMARY IMMUNODEFICIENCY DISEASES (PID), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test Lab-Based gene fix for rare immune diseases
Knowledge-focused Recruiting nowThis research aims to understand how JAK-inhibitor drugs affect immune cells in people with rare genetic immune disorders. Researchers will study blood samples from 20 adult participants to see how these drugs change cell behavior and test whether a gene therapy approach could co…
Matched conditions: PRIMARY IMMUNODEFICIENCY DISEASES (PID)
Phase: NA • Sponsor: prof. dr. Rik Schrijvers • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:32 UTC
-
Drug safety under review: study scans patient records for rare reactions
Knowledge-focused Recruiting nowThis study aims to check the safety of an existing treatment called Cuvitru in people with primary immunodeficiency (PID). Researchers will look back at the medical records of about 100 patients in Japan to see if they experienced specific, serious side effects. The goal is to ga…
Matched conditions: PRIMARY IMMUNODEFICIENCY DISEASES (PID)
Sponsor: Takeda • Aim: Knowledge-focused
Last updated Mar 02, 2026 15:21 UTC